Falotico, J. M., Lapides, R., & Lipner, S. R. (2022, March). Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials. Journal of Fungi.
Chicago Style (17th ed.) CitationFalotico, Julianne M., Rebecca Lapides, and Shari R. Lipner. "Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials." Journal of Fungi Mar. 2022.
MLA (9th ed.) CitationFalotico, Julianne M., et al. "Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials." Journal of Fungi, Mar. 2022.
Warning: These citations may not always be 100% accurate.